Cargando…

Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin

OBJECTIVES: P90 ribosomal S6 kinase (RSK) 1 and 2 are serine/threonine protein kinases believed to mediate proliferation and apoptosis via the extracellular signal-regulated kinases (ERK1/2) signaling pathway. Macrophage migration inhibitory factor (MIF) and epidermal growth factor (EGF) are activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Mads K, Nielsen, Jakob, Kjellerup, Rasmus B, Andersen, Stine M, Rittig, Anne H, Johansen, Claus, Iversen, Lars, Gesser, Borbala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735993/
https://www.ncbi.nlm.nih.gov/pubmed/29290690
http://dx.doi.org/10.2147/JIR.S152869
_version_ 1783287311301083136
author Rasmussen, Mads K
Nielsen, Jakob
Kjellerup, Rasmus B
Andersen, Stine M
Rittig, Anne H
Johansen, Claus
Iversen, Lars
Gesser, Borbala
author_facet Rasmussen, Mads K
Nielsen, Jakob
Kjellerup, Rasmus B
Andersen, Stine M
Rittig, Anne H
Johansen, Claus
Iversen, Lars
Gesser, Borbala
author_sort Rasmussen, Mads K
collection PubMed
description OBJECTIVES: P90 ribosomal S6 kinase (RSK) 1 and 2 are serine/threonine protein kinases believed to mediate proliferation and apoptosis via the extracellular signal-regulated kinases (ERK1/2) signaling pathway. Macrophage migration inhibitory factor (MIF) and epidermal growth factor (EGF) are activators of this pathway and are elevated in the serum of patients with psoriasis compared with healthy controls. Studies on COS-7 cell cultures have shown that protein phosphatase 2Cδ (PP2Cδ) decreases the activity of RSK2 following EGF stimulation. We therefore hypothesize that PP2Cδ regulates RSK2 activity in psoriasis. METHODS: In paired biopsies from nonlesional (NL) and lesional (L) skins, we analyzed the level of RSK1, 2 phosphorylation and the expression of PP2Cδ isoforms, integrin-linked kinase-associated serine/threonine phosphatase (ILKAP) and wild-type p53-induced phosphatase 1 (Wip1) by Western blotting, immunofluorescence and coimmunoprecipitation with monoclonal antibody for RSK2. The induction of Wip1 by MIF or EGF was studied in cultured normal human keratinocytes. RESULTS: The protein level of RSK1, 2 phosphorylated at T573/T577 was significantly increased in L compared with NL psoriatic skin, while phosphorylation at S380/S386 was reduced in L compared with NL psoriatic skin when assayed by Western blotting and immunofluorescence microscopy. ILKAP expression was significantly higher in L than in NL skin, whereas Wip1 was expressed in similar amounts but showed increased coimmunoprecipitation with RSK2 in L compared with NL psoriatic skin. In cultured normal human keratinocytes stimulated with MIF, Wip1 phosphorylation and Wip1 expression were increased after 24 hours, but not when costimulated with dimethyl fumarate (DMF). The increased coimmunoprecipitation of Wip1 with RSK2 was significantly induced by EGF or MIF activation at 24 hours and could be significantly inhibited by DMF or the ERK1/2 inhibitor PD98059. CONCLUSION: The complex formation of Wip1 with RSK2 indicates a direct interaction reducing P-RSK2 (S386) activation in L skin and indicates that Wip1 has a role in the pathogenesis of psoriasis.
format Online
Article
Text
id pubmed-5735993
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57359932017-12-29 Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin Rasmussen, Mads K Nielsen, Jakob Kjellerup, Rasmus B Andersen, Stine M Rittig, Anne H Johansen, Claus Iversen, Lars Gesser, Borbala J Inflamm Res Original Research OBJECTIVES: P90 ribosomal S6 kinase (RSK) 1 and 2 are serine/threonine protein kinases believed to mediate proliferation and apoptosis via the extracellular signal-regulated kinases (ERK1/2) signaling pathway. Macrophage migration inhibitory factor (MIF) and epidermal growth factor (EGF) are activators of this pathway and are elevated in the serum of patients with psoriasis compared with healthy controls. Studies on COS-7 cell cultures have shown that protein phosphatase 2Cδ (PP2Cδ) decreases the activity of RSK2 following EGF stimulation. We therefore hypothesize that PP2Cδ regulates RSK2 activity in psoriasis. METHODS: In paired biopsies from nonlesional (NL) and lesional (L) skins, we analyzed the level of RSK1, 2 phosphorylation and the expression of PP2Cδ isoforms, integrin-linked kinase-associated serine/threonine phosphatase (ILKAP) and wild-type p53-induced phosphatase 1 (Wip1) by Western blotting, immunofluorescence and coimmunoprecipitation with monoclonal antibody for RSK2. The induction of Wip1 by MIF or EGF was studied in cultured normal human keratinocytes. RESULTS: The protein level of RSK1, 2 phosphorylated at T573/T577 was significantly increased in L compared with NL psoriatic skin, while phosphorylation at S380/S386 was reduced in L compared with NL psoriatic skin when assayed by Western blotting and immunofluorescence microscopy. ILKAP expression was significantly higher in L than in NL skin, whereas Wip1 was expressed in similar amounts but showed increased coimmunoprecipitation with RSK2 in L compared with NL psoriatic skin. In cultured normal human keratinocytes stimulated with MIF, Wip1 phosphorylation and Wip1 expression were increased after 24 hours, but not when costimulated with dimethyl fumarate (DMF). The increased coimmunoprecipitation of Wip1 with RSK2 was significantly induced by EGF or MIF activation at 24 hours and could be significantly inhibited by DMF or the ERK1/2 inhibitor PD98059. CONCLUSION: The complex formation of Wip1 with RSK2 indicates a direct interaction reducing P-RSK2 (S386) activation in L skin and indicates that Wip1 has a role in the pathogenesis of psoriasis. Dove Medical Press 2017-12-15 /pmc/articles/PMC5735993/ /pubmed/29290690 http://dx.doi.org/10.2147/JIR.S152869 Text en © 2017 Rasmussen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Rasmussen, Mads K
Nielsen, Jakob
Kjellerup, Rasmus B
Andersen, Stine M
Rittig, Anne H
Johansen, Claus
Iversen, Lars
Gesser, Borbala
Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
title Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
title_full Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
title_fullStr Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
title_full_unstemmed Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
title_short Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
title_sort protein phosphatase 2cδ/wip1 regulates phospho-p90rsk2 activity in lesional psoriatic skin
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735993/
https://www.ncbi.nlm.nih.gov/pubmed/29290690
http://dx.doi.org/10.2147/JIR.S152869
work_keys_str_mv AT rasmussenmadsk proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT nielsenjakob proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT kjelleruprasmusb proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT andersenstinem proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT rittiganneh proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT johansenclaus proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT iversenlars proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin
AT gesserborbala proteinphosphatase2cdwip1regulatesphosphop90rsk2activityinlesionalpsoriaticskin